{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:10:45Z","timestamp":1793653845377,"version":"4.5.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Methadone treatment is effective for managing opioid use disorder (OUD) but raises concerns about its impact on cardiac function. This study aimed to assess the prevalence of cardiac dysfunction among individuals under methadone treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This cross-sectional study involved 200 OUD patients admitted to addiction treatment centers of Kerman, Iran, who were at least 1 year under methadone maintenance therapy. Participants were enrolled using a convenience sampling method. Exclusion criteria included concurrent alcohol or nonopioid drug abuse, underlying diseases affecting cardiac function (diabetes, hypertension, and chronic renal failure), hepatic diseases, or use of drugs affecting methadone metabolism. Data on methadone dose, treatment duration, and cardiac parameters assessed through echocardiography and electrocardiography were collected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings:<\/jats:title>\n                    <jats:p>A total of 200 OUD patients aged 46.34 \u00b1 13.93 years (72% male) were included. The average duration of methadone use was 2.17 \u00b1 1.34 years, and the average dose was 52.10 \u00b1 27.46 mg\/day. 38% of subjects had QT prolongation, while echocardiographic assessment revealed various cardiac abnormalities: 17.5% with systolic dysfunction, 12.5% with abnormal left ventricular end-diastolic diameter, 66.5% with diastolic dysfunction, and 15.5% with increased systolic pulmonary artery pressure. Significant correlations were observed between methadone dose and duration with all measured cardiac parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study demonstrated an association between methadone treatment characteristics (higher dose and longer duration) and cardiac dysfunction. These findings suggest dose- and time-dependent cardiotoxic effects of methadone. Clinicians should implement cardiac monitoring, dose minimization, and risk-reduction strategies for patients on long-term methadone therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jrpp.jrpp_15_25","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T06:00:13Z","timestamp":1754546413000},"page":"59-65","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Cardiac Assessment of Individuals with Opioid Use Disorder under Methadone Treatment"],"prefix":"10.4103","volume":"14","author":[{"given":"Hoda","family":"Barkhordari","sequence":"first","affiliation":[{"name":"Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Masoumi","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Moazenzadeh","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Esmaili","sequence":"additional","affiliation":[{"name":"Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Rashidinejad","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"R1-20260423","doi-asserted-by":"crossref","first-page":"n784","DOI":"10.1136\/bmj.n784","article-title":"Treatment of opioid use disorder in primary care","volume":"373","author":"Buresh","year":"2021","journal-title":"BMJ"},{"key":"R2-20260423","first-page":"1","article-title":"Opioid use disorder","volume":"6","author":"Strang","year":"2020","journal-title":"Nat Rev Dis Prim"},{"key":"R3-20260423","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob Health"},{"key":"R4-20260423","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/epirev\/mxaa012","article-title":"The worldwide opioid pandemic: Epidemiologic perspectives","volume":"42","author":"Celentano","year":"2020","journal-title":"Epidemiol Rev"},{"key":"R6-20260423","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1080\/14656566.2016.1244529","article-title":"Update on pharmacotherapy for treatment of opioid use disorder","volume":"17","author":"Ayanga","year":"2016","journal-title":"Expert opinion on Pharmacotherapy"},{"key":"R7-20260423","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2217\/pgs.14.56","article-title":"Pharmacogenomics of methadone maintenance treatment","volume":"15","author":"Somogyi","year":"2014","journal-title":"Pharmacogenomics"},{"key":"R8-20260423","first-page":"104","article-title":"Methadone related poisoning on the rise in Tehran, Iran","volume":"3","author":"Soltaninejad","year":"2014","journal-title":"Asia Pac J Med Toxicol"},{"key":"R9-20260423","doi-asserted-by":"crossref","first-page":"103529","DOI":"10.1016\/j.drugpo.2021.103529","article-title":"Public health risks associated with methadone in Iran: A systematic review and meta-analysis","volume":"100","author":"Rostam-Abadi","year":"2022","journal-title":"Int J Drug Policy"},{"key":"R10-20260423","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/jpp.JPP_163_17","article-title":"Comprehensive review on methadone-induced QT prolongation and torsades","volume":"9","author":"Treece","year":"2018","journal-title":"J Pharmacol Pharmacother"},{"key":"R11-20260423","first-page":"577","article-title":"A systematic review of the cardiotoxicity of methadone","volume":"14","author":"Alinejad","year":"2015","journal-title":"EXCLI J"},{"key":"R12-20260423","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/jclp.23582","article-title":"Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder","volume":"79","author":"Wang","year":"2023","journal-title":"J Clin Psychol"},{"key":"R13-20260423","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S2215-0366(23)00095-0","article-title":"Buprenorphine versus methadone for the treatment of opioid dependence: A systematic review and meta-analysis of randomised and observational studies","volume":"10","author":"Degenhardt","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"R14-20260423","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jpainsymman.2004.06.012","article-title":"Measurement of QTc in patients receiving chronic methadone therapy","volume":"29","author":"Cruciani","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"R15-20260423","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000081416","article-title":"QTc interval prolongation in patients on long-term methadone maintenance therapy","volume":"11","author":"Maremmani","year":"2005","journal-title":"Eur Addict Res"},{"key":"R16-20260423","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.amjcard.2004.11.055","article-title":"Impact of methadone treatment on cardiac repolarization and conduction in opioid users","volume":"95","author":"Martell","year":"2005","journal-title":"Am J Cardiol"},{"key":"R17-20260423","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1592\/phco.23.6.802.32186","article-title":"Dose\u2010related effects of methadone on QT prolongation in a series of patients with torsade de pointes","volume":"23","author":"Krantz","year":"2003","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"R18-20260423","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11883-017-0656-z","article-title":"The role for cardiovascular remodeling in cardiovascular outcomes","volume":"19","author":"Sekaran","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"R19-20260423","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.clpt.6100120","article-title":"Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers","volume":"81","author":"Eap","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"R20-20260423","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.pbiomolbio.2007.07.011","article-title":"Contributions of HERG K+ current to repolarization of the human ventricular action potential","volume":"96","author":"Fink","year":"2008","journal-title":"Prog Biophys Mol Biol"},{"key":"R21-20260423","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2146\/ajhp070392","article-title":"Methadone-associated Q-T interval prolongation and torsades de pointes","volume":"66","author":"Stringer","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"R22-20260423","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1592\/phco.29.5.495","article-title":"Electrocardiographic effects of lofexidine and methadone coadministration: Secondary findings from a safety study","volume":"29","author":"Schmittner","year":"2009","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"R23-20260423","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/15563650701502691","article-title":"Hemodynamic effects of methadone and dihydrocodeine in overdose","volume":"45","author":"Afshari","year":"2007","journal-title":"Clin Toxicol (Phila)"}],"container-title":["Journal of Research in Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jrpp.jrpp_15_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:05:55Z","timestamp":1787774755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jrpp.jrpp_15_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jrpp.jrpp_15_25","relation":{},"ISSN":["2319-9644","2279-042X"],"issn-type":[{"value":"2319-9644","type":"print"},{"value":"2279-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2025-03-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}